The Oklahoma City Thunder’s injury crisis deepened on Friday as the franchise confirmed star center Chet Holmgren will miss eight to ten weeks. The team announced that Holmgren underwent a successful biological treatment for a small patellar tendon tear in his right knee. This significant absence removes a cornerstone of the Thunder’s defensive scheme and offensive rebounding engine during a critical stretch of the NBA season.
Thunder’s frontcourt depth tested as star center undergoes successful biological treatment
Holmgren initially reported mild discomfort in his knee earlier this week, prompting a detailed assessment by medical specialists. Following the consultation, the 23-year-old opted for the non-surgical intervention, which the Thunder described as successful. While the team has not provided a specific return date, the eight-to-ten-week timeline suggests Holmgren will be sidelined until late January or early February, depending on his recovery progress.
The Thunder will now lean heavily on their remaining frontcourt options to maintain their elite defensive rating. With Holmgren’s unique combination of size and mobility off the floor, Oklahoma City must rely on veteran depth and aggressive defensive rotations to protect the paint. This injury marks a pivotal moment for the Thunder’s championship aspirations, testing their ability to sustain high-level performance without their most versatile big man.
Source: Yahoo Sports
